Catalyst Wire Dossier Catalyst Wire Dossier

INR101 Injection

INR101 · Yunhe Pharmaceutical (Tianjin) Co., Ltd
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for INR101 Injection, covering 2024-10-30 to 2025-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer. [Phase 3]

See pricing